Katie Hasson

Katie Hasson, PhD, writes, speaks, researches, and teaches about the social and political aspects of human genetic and reproductive technologies. Katie earned her PhD in Sociology with a Designated Emphasis in Women, Gender, and Sexuality from the University of California, Berkeley, and was previously Assistant Professor of Sociology and Gender Studies at the University of Southern California.

Profile picture for user Katie Hasson

Publications

photo of a world cloud
By Katie Hasson and Marcy Darnovsky, Development Journal | 01.14.2020

As genetic technologies merge with forensics, medicine, and human reproduction, renewed eugenic temptations are arising. The prospect of heritable genetic...

An embryo being fertilized
By Katie Hasson, The Hill | 06.10.2019

Late last year, scientist He Jiankui announced the birth of the world’s first genetically modified babies. He deployed a...

Gloved hands moving small test tubes from one test tube rack to another
By Katie Hasson and Marcy Darnovsky, The Guardian | 11.27.2018

The fierce global controversy over whether to alter the genes of future children and generations just got fiercer. On the...

In the News

DNA strands
By Mary Annette Pember, ICT News [cites CGS' Katie Hasson] | 04.18.2025

The sight of a room full of human cadavers can be off-putting for some, but not for Haley Omeasoo.

In...

graphic with babies elevated with arrows on yellow background
By Staff [cites CGS' Katie Hasson], Radio New Zealand | 04.05.2025

At a time where some countries are struggling with low birth rates, the voices for pronatalism are getting louder.  But...

DNA graphic
By Lisa Eadicicco, CNN [cites CGS' Katie Hasson] | 03.30.2025

23andMe, a standard-bearer for the at-home health movement, announced on March 23 that it has filed for Chapter 11 bankruptcy...

Biopolitical Times

This week in London, some 400 people from around the world – including scientists, bioethicists, patients, journalists, civil society groups...

 Rehua, CC BY-SA 3.0, via Wikimedia Commons

James Wilson, director of the Gene Therapy Program at Penn’s...